Abstract Treatment of Helicobacter pylori (H. pylori) infection is paramount for the
management of prevalent gastrointestinal disorders including peptic ulcer disease and …

Helicobacter pylori (H. pylori) is a major human pathogen associated with significant
morbidity and mortality. However, after decades of efforts, treatment of H. pylori remains a …

AIM: The eradication rate of Helicobacter pylori (H pylori) shows variation among countries
and regimens of treatment. We aimed to study the eradication rates of different regimens in …

Background With the wide use of antibiotics, antibiotic-resistant Helicobacter pylori strains
are becoming increasingly prevalent. It has been hypothesized that culture-guided therapy …

Objective To evaluate the primary, secondary and combined resistance to five antimicrobial
agents of 2340 Helicobacter pylori isolates from 19 centers in 10 countries in eastern …

Background: Triple therapy with proton pump inhibitor, clarithromycin and amoxicillin has
recently been proposed in Maastricht as first‐line treatment for H. pylori infection. Aim: To …

Currently available Helicobacter pylori eradication therapies are considered very effective
and safe. The most recent eradication guidelines proposed in the Maastricht 2‐2000 …

With the rising prevalence of antimicrobial resistance, the eradication rates of Helicobacter
pylori (H. pylori) with standard treatments are decreasing to unacceptable levels (ie,≤ 80%) …

Indroduction: Treatment of Helicobacter pylori (H. pylori) infection is crucial for prevalent
disease's management, including gastritis, peptic ulcer and gastric cancer, whereas novel …

幽门螺杆菌(Helicobacter pylori, H. pylori) 的发现已有20 年的历史. 近20 年来,
在胃肠病工作者全面而深入的研究下, H. pylori 已被确认是慢性胃炎和大部分消化性溃疡的重要 …